Similar Articles
Macular Degeneration and Treatment
Mine Ün, Sedef Öztürk
DOI: 10.5606/jebms.2020.75600
Issue: 2020, Volume 1 - Issue 1
1114
1127
Migraine and Calcitonin Gene-Related Peptide Receptor Antagonist Treatment
Yasemin Akbaş
DOI: 10.5606/jebms.2020.75617
Issue: 2020, Volume 1 - Issue 2
1013
996
Familial Autism Genes
Ezgi Seda Yayla
DOI: 10.5606/jebms.2020.75621
Issue: 2020, Volume 1 - Issue 3
1137
1068
What Does CRISPR Technology Provide to Cancer Treatments?
Güner Yaman, Nilsu Çini, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2021.75637
Issue: 2021, Volume 2 - Issue 1
1335
803
Multiple Myeloma Treatment
Edanur Tekin, Özge Çağlar, Elif Özyılmaz, Oytun Erbaş
DOI: 10.5606/jebms.2021.75658
Issue: 2021, Volume 2 - Issue 2
666
596
Metformin as Cancer Preventative and Therapeutic Agent
İlayda Üzümcü, Burak Akverdi, Elif Ünaldı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1006
Issue: 2022, Volume 3 - Issue 1
937
561
Depression and Cardiovascular Disease: A Mutual Relationship
Bahar Işık,Oytun Erbaş
DOI: 10.5606/jebms.2023.1041
Issue: 2023, Volume 4 - Issue 1
512
551
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Issue: 2023, Volume 4 - Issue 2
529
479
Revolutionizing Health Technologies: The Transformative Power of Stem Cells
Tutku Özaydın, Kerem Can Tunç, Oytun Erbaş
DOI: 10.5606/jebms.2024.1071
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
330
340
Stem Cell Applications: A Promising Future for Autoimmune Diseases?
Öznur Safgöl, Oytun Erbaş
DOI: 10.5606/jebms.2024.1075
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
317
344
Stem Cells in Surgery
Buse Kaptan, Oytun Erbaş
DOI: 10.5606/jebms.2024.1080
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
321
282
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
411
303